165 OUTCOMES OF INTRADETRUSOR INJECTION OF ONABOTULINUMTOXINA (BTX-A) FOR OVERACTIVE BLADDER IN THE ELDERLY POPULATION.

165 OUTCOMES OF INTRADETRUSOR INJECTION OF ONABOTULINUMTOXINA (BTX-A) FOR OVERACTIVE BLADDER IN THE ELDERLY POPULATION.

Bibliographic Details
Main Authors:	N Hernandez, R Stading, L Miceli, J Stewart, D Antosh, K Williams, F Lindo, R Gonzalez, R Khavari
Format:	Article
Language:	English
Published:	Elsevier 2022-06-01
Series:	Continence
Online Access:	http://www.sciencedirect.com/science/article/pii/S2772973722005665

Similar Items

Low dose intradetrusor injections of onabotulinumtoxina in women with overactive bladder symptoms or the painful bladder syndrome: unfavourable balance between clinical efficacy and the need for catheterisation
by: Jan Groen, et al.
Published: (2012-01-01)

Low dose intradetrusor injections of onabotulinumtoxinA in women with overactive bladder symptoms or the painful bladder syndrome: unfavorable balance between clinical efficacy and the need for catheterization
by: Jan Groen, et al.
Published: (2012-10-01)

Effectiveness and Safety of Intradetrusor OnabotulinumtoxinA Injection for Neurogenic Detrusor Overactivity and Overactive Bladder Patients in Taiwan—A Phase IV Prospective, Interventional, Multiple-Center Study (Restore Study)
by: Chung-Cheng Wang, et al.
Published: (2021-12-01)

71 - Onabotulinum toxin A (BTX-A) intradetrusor injections in children with neurogenic bladder dysfunction: Long-term histological effects on bladder wall
by: Chiara Pellegrino, et al.
Published: (2023-06-01)

OnabotulinumtoxinA for the treatment of overactive bladder
by: Cox L, et al.
Published: (2014-07-01)

Intravesical Loss of OnabotulinumtoxinA During Endoscopic Intradetrusor Injection - A Multicenter Experience
by: Vladimír Šámal, et al.
Published: (2020-03-01)

Experience of onabotulinumtoxinA (Botox) treatment for overactive bladder in outpatient clinic with less number of injections
by: A.K. Habib, et al.
Published: (2020-07-01)

Intradetrusor onabotulinumtoxinA injections are significantly more efficacious than oral oxybutynin for treatment of neurogenic detrusor overactivity: results of a randomized, controlled, 24-week trial
by: Rúiter Silva Ferreira, et al.

Outcomes of Intradetrusor Onabotulinum Toxin A Therapy in Overactive Bladder Refractory to Sacral Neuromodulation
by: Hamilton Trinh, et al.
Published: (2019-09-01)

Factors Associated with Therapeutic Efficacy of Intravesical OnabotulinumtoxinA Injection for Overactive Bladder Syndrome.
by: Sheng-Mou Hsiao, et al.
Published: (2016-01-01)

Efficacy and safety of intravesical onabotulinumtoxinA injection on elderly patients with chronic central nervous system lesions and overactive bladder.
by: Yuan-Hong Jiang, et al.
Published: (2014-01-01)

Time of onset and factors associated with delayed response post intradetrusor injection of onabotulinumtoxin a in patients with neurogenic and idiopathic overactive bladder syndrome
by: Tariq Faisal Al-Shaiji, et al.
Published: (2023-01-01)

New developments in the management of overactive bladder: focus on mirabegron and onabotulinumtoxinA
by: Andersson KE
Published: (2013-04-01)

Editorial Comment: Solifenacin treatment after intradetrusor injections with botulinum toxin in patients with neurogenic detrusor overactivity
by: Marcio Augusto Averbeck
Published: (2022-11-01)

A Feasibility Study to Evaluate Changes in Urinary Metabolites after OnabotulinumtoxinA Injection for Refractory Overactive Bladder
by: Laura M. Tellechea, et al.
Published: (2022-09-01)

Intravesical OnabotulinumtoxinA Injection for Overactive Orthotopic Ileal Neobladder: Feasibility and Efficacy
by: Nathan Hoag, et al.
Published: (2016-03-01)

Intradetrusor OnabotuliniumtoxinA injection for refractory bladder spasms before vesicovaginal fistula repair
by: Evan Sirls, et al.
Published: (2023-01-01)

ANATOMICAL LOCATION AND NUMBER OF INJECTION SITES OF INTRAVESICAL ONABOTULINUMTOXINA FOR FEMALES WITH REFRACTORY IDIOPATHIC OVERACTIVE BLADDER - A SYSTEMATIC SCOPING REVIEW
by: E Kelsey, et al.
Published: (2023-09-01)

Trigonal-Sparing vs. Trigonal-Involved OnabotulinumtoxinA Injection for the Treatment of Overactive Bladder: A Systematic Review and Meta-Analysis
by: Yuanshan Cui, et al.
Published: (2021-10-01)

LONG-TERM EFFECTS ON BLADDER WALL OF REPEATED INTRADETRUSOR INJECTIONS OF ONABOTULINUM TOXIN A IN CHILDREN WITH NEUROGENIC BLADDER DYSFUNCTION.
by: G Mosiello, et al.
Published: (2023-09-01)

Editorial Comment: Long-term outcomes and risks factors for failure of intradetrusor onabotulinumtoxin A injections for the treatment of refractory neurogenic detrusor overactivity
by: Marcio Augusto Averbeck
Published: (2021-02-01)

Overactive bladder in the vulnerable elderly
by: Wolff GF, et al.
Published: (2014-10-01)

The Effects of Age, Gender, and Postvoid Residual Volume on Catheterization Rates After Treatment with OnabotulinumtoxinA for Overactive Bladder
by: Roger Dmochowski, et al.
Published: (2023-11-01)

Assessment of Anticholinergic Use After Fading of BTX-A Effects in Refractory Idiopathic Overactive Bladder: A Prospective Blinded Randomized Trial
by: M.A. Elbaset, et al.
Published: (2019-09-01)

Does Reduction of Number of Intradetrusor Injection Sites of aboBoNTA (Dysport®) Impact Efficacy and Safety in a Rat Model of Neurogenic Detrusor Overactivity?
by: Amélie Huynh Le Maux, et al.
Published: (2015-12-01)

Efficacy and Safety of Low-Dose Intravesical OnabotulinumtoxinA Injections in Female Patients With Detrusor Overactivity With Detrusor Underactivity
by: Hyun Seok Na, et al.
Published: (2024-03-01)

Retrospective Observational Study of Treatment Patterns and Efficacy of onabotulinumtoxinA Therapy in Patients with Refractory Overactive Bladder in Clinical Practice
by: Kwang Jin Ko, et al.
Published: (2023-05-01)

Transvaginal ultrasound guided trigone and bladder injection: A cadaveric feasibility study for a novel route of intradetrusor chemodenervation
by: Raveen Syan, et al.
Published: (2019-01-01)

EFFICACY OF INTRADETRUSOR PLATELET-RICH PLASMA INJECTION IN TREATMENT OF INTERSTITIAL CYSTITIS
by: V Medvedev, et al.
Published: (2023-09-01)

OnabotulinumtoxinA in the treatment of neurogenic bladder
by: Gulamhusein A, et al.
Published: (2012-08-01)

A Korean Postmarketing Study Assessing the Effectiveness of OnabotulinumtoxinA for the Treatment of Neurogenic Detrusor Overactivity or Idiopathic Overactive Bladder Using a Validated Patient-Reported Outcome Measure
by: Kwang Jin Ko, et al.
Published: (2019-03-01)

The Effects of Intradetrusor BoNT-A Injections on Vesicoureteral Reflux in Children With Myelodysplasia
by: Tuncay Toprak, et al.
Published: (2019-12-01)

Overactive bladder in males
by: Alex Gomelsky, et al.
Published: (2009-10-01)

Onabotulinum Toxin A Intradetrusor Injections in Children with Neurogenic Lower Urinary Tract Dysfunction: Long-Term Histological Effects on the Bladder Wall
by: Chiara Pellegrino, et al.
Published: (2023-04-01)

Therapeutic outcome and patient adherence to repeated onabotulinumtoxinA detrusor injections in chronic spinal cord-injured patients and neurogenic detrusor overactivity
by: Sheng-Fu Chen, et al.
Published: (2015-07-01)

Studies of relationships between overactive bladder and frailty in the elderly
by: M. Yoshida, et al.
Published: (2020-07-01)

Overactive bladder
by: Anna Zwierzyńska
Published: (2021-07-01)

The overactive bladder
by: Richard Foon, et al.
Published: (2010-08-01)

Refractory overactive bladder patients who chose sacral neuromodulation therapy after failed OnabotulinumtoxinA treatment: A systematic review and meta-analysis.
by: Guang Yang, et al.
Published: (2020-01-01)

The Experimental overactive bladder modelling
by: O. I. Iatsyna, et al.
Published: (2018-07-01)